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Introduction
The small intestinal epithelium provides a barrier between the 
microorganism-rich intestinal lumen and the underlying stroma. 
Epithelial cells are constantly renewed from the stem cell niche at 
the crypt bottoms and migrate until reaching villus tips after dif-
ferentiation (1). Sharp morphogen gradients control this polarized 
structure, including high Wnt and Notch signaling in the crypts and 
high TGF-β/BMP and Hh signaling in villi (1). Furthermore, the 
small intestine is unique in its role in immunity, as the gut harbors 
billions of microbes, and retinoic acid–driven fine-tuning of special-
ized immune cells ensures proper intestinal homeostasis (2). The 
intestine is a site of strong mechanical forces as well, as continuous 
piston-like villus contractions and peristaltic movement of the gut 
wall promote both absorption and movement of food particles (3).
The intestinal vasculature plays a key role in the regulation of 
nutrient absorption and gut immune function. Amino acids, car-
bohydrates, and short- and medium-chain fatty acids are taken up 
by blood capillaries in the villi for systemic distribution. Further-
more, retinoic acid–imprinted tolerogenic regulatory T cells home 
to the gut via intestinal microvasculature, and they play a key role 
in intestinal tolerance toward dietary antigens and the microbi-
ota (4). Specialized lymphatic vessels in the villi, called lacteals, 
absorb long-chain fatty acids and fat-soluble vitamins. In addi-
tion to fat transport, lymphatic vessels of the gut serve as a main 
route for transport of microbial antigens and antigen-presenting 
cells to the mesenteric lymph node, including dietary vitamin A/
retinoic acid–programmed CD103+ DCs. Such DCs migrate to the 
draining mesenteric lymph nodes, where they present retinoic 
acid along with processed antigen to T cells to endow them with 
gut-homing properties (2, 4).
Lacteals form during late embryogenesis and in the early 
postnatal period and expand into the villus by P7 (5, 6). Signal-
ing via VEGFR3 and its coreceptor neuropilin 2 (NRP2) plays 
a key role in inducing postnatal sprouting and lacteal growth 
(6, 7). Disruption of intestinal lymphatic vasculature in adult 
mice leads to acute failure of immune surveillance systems 
in the small intestine and rapid lethality, underscoring the 
importance of intestinal lymphatic vessels in immune homeo-
stasis (8). Impairment of lymphatic vascular function has  also 
recently been implicated in the pathology of inflammatory 
bowel disease, where blocking lymphangiogenesis led to fur-
ther disease exacerbation (9, 10). Mice with targeted inacti-
vation of the transcription factor T-box transcription factor 1 
(TBX1) have severe hypoplasia of mesenteric lymphatic vessels 
(11), and patterning of intestinal lymphatic vessels is perturbed 
in mice mutant for Pik3r1, encoding the p85α, p55α, and p50α 
subunits of PI3K (12). Human dermal and small intestinal lym-
phatic endothelial cells (LECs) have related but distinct gene 
expression profiles (13); however, to date, few studies reported 
mechanisms regulating adult small intestinal lymphatic ves-
sels. Yet pathological conditions arise in adults in the context 
of highly specialized organ microenvironments; therefore, 
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1A). Intestinal lymphatic capillaries called lacteals — stained 
with LYVE1 (Figure 1B) but also positive for VEGFR2 (Figure 1A 
and Supplemental Figure 1B; supplemental material available 
online with this article; doi:10.1172/JCI82045DS1) and VEGFR3 
(Supplemental Figure 1A) — were located in the villus center 
and are spatially separated from blood vessels (Figure 1B). As 
expected, NG2 staining identified pericytes closely associated 
with villus blood capillaries (Figure 1C) and a dense network of 
cells between villus epithelial cells and blood capillaries, which 
are most likely subepithelial myofibroblasts (20). Although pre-
vious studies in tissue sections suggested the presence of vascu-
lar smooth muscle cells (SMCs) on lacteals and blood capillaries 
(21, 22), we failed to confirm this observation in our 3D analy-
sis (Figure 1, D and E). Instead, in agreement with high villus 
contractility (23), we observed tree-like smooth muscle fibers 
(Figure 1, D–F), identified by α–smooth muscle actin (αSMA) 
and desmin staining (Supplemental Figure 1C). αSMA+/desmin+ 
cells have been previously observed in intestinal villi (24), and 
αSMA–desmin+ cells most likely are subepithelial myofibro-
there is a marked significant need for a better understanding 
of the principles of adult lymphatic vasculature organization 
and maintenance in a tissue-specific context. Here, we provide 
a detailed 3D analysis of the adult small intestinal stroma and 
show that, unlike other adult lymphatic vascular beds, lacteals 
undergo continuous remodeling. We further report that such 
remodeling and maintenance of lacteals relies on delta-like 4 
(DLL4), which promotes both the survival and regeneration of 
these vessels.
Results
Small intestinal stroma organization. Although intestinal epithe-
lial and immune cells are being intensely studied (1, 14–19), less 
focus has been given to other cell types in the small intestine. 
Using a whole-mount staining approach, we analyzed the 3D 
organization of the stroma of small intestinal villi. In agreement 
with their key role in nutrient absorption, villus blood capillaries, 
identified by staining for VEGFR2, form a well-organized cage-
like structure in apposition to intestinal epithelial cells (Figure 
Figure 1. Unique organization of small intestinal stroma. 
Confocal microscope images of adult mouse small 
intestinal villi after whole-mount immunostaining. (A) 
A dense blood capillary network (VEGFR2, green) lies in 
close proximity to intestinal epithelial cells (E-cadherin, 
red). (B) Adult lacteals (LYVE1, red) and villus blood vessels 
(PECAM1, green) in adult small intestine. (C) Pericytes (NG2, 
green, arrowheads) are closely associated with villus blood 
capillaries (VEGFR2, red). (D) αSMA (red) staining reveals 
a network of SMCs in the villi, located inside the blood 
capillary network (green). MM, muscularis mucosa; CM, 
circular muscle; LM, longitudinal muscle. (E) A subset of 
villus SMCs (αSMA, cyan) are in close proximity to lacteals 
(LYVE1, red). (F) Higher-magnification view of near lacteal 
villus SMCs (αSMA, cyan). (G) Terminal ends of villus SMCs 
(αSMA, red) interact with villus blood vessels (PECAM1, 
green). Nuclei are stained with DAPI (blue). Ep, epithelial 
cells. Scale bars: 50 μm, A–D; 20 μm, E; 10 μm, F; 5 μm, G.
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lar signaling and migration (25). Integrin α9 is highly expressed 
in LECs, and mechanosignaling, through β1 integrins, promotes 
VEGFR3 phosphorylation and LEC survival, proliferation, and 
migration (26). However, we found that in intestinal stroma, the 
highest levels of both fibronectin-binding integrins are found 
in villus SMCs, with weaker expression on lacteal LECs (Sup-
plemental Figure 1E). As reported previously for other vascular 
beds, blood endothelial cells (BECs) and LECs expressed com-
parable levels of Itgb1, while Itga9 was preferentially expressed 
on LECs (Supplemental Figure 1F and ref. 27). Tenascin C, a 
matricellular protein induced upon tissue stretching, injury, and 
inflammation (28), was abundantly expressed in the villus and 
was almost undetectable in the submucosa (Figure 2C). At the 
same time, another ECM component, periostin, important for 
Wnt signaling (29), was present mostly in pericryptal fibroblasts, 
as previously reported (Figure 2C and ref. 30). Taken together, 
our data revealed a highly specialized and unique organization of 
the intestinal stromal compartment in adult animals.
Adult lacteals are continuously regenerating. (Lymph)angio-
genesis is initiated in response to a reduced oxygen/nutrient 
supply, increased inflammation, or interstitial fluid pressure 
(26, 31). It is characterized by coordinated migration and 
increased proliferation of LECs or BECs in response to VEGFA 
or VEGFC until metabolic or fluid drainage requirements of the 
tissue or organ are met. It is necessary for proper embryonic 
development and is a feature of many pathological conditions 
(31, 32). In contrast, most adult vascular networks are quiescent 
and growth factor independent (33, 34). Examination revealed 
that filopodia were present in 75% of lacteals but were absent 
in submucosal lymphatics (Figure 3A and data not shown). As 
expected, lymphatic capillaries in other organs, such as skin, 
were blind ended and devoid of filopodia, which is typical for 
quiescent lymphatic vessels (Figure 3A). During embryonic 
development, lymphatic sprouting and filopodia formation are 
associated with LEC proliferation (31, 32). Therefore, we ana-
lyzed small intestinal LEC proliferation using the proliferation 
marker Ki67 and lymphatic endothelial marker PROX1 (35). As 
expected, strong Ki67 staining could be observed in intestinal 
crypt epithelial cells; however, virtually no Ki67+ LECs were 
detected in the intestinal submucosa, and only 2.5% of villus 
LECs were Ki67+ (Figure 3B). In addition, as expected, only 
0.2% of LECs observed in adult ear skin were Ki67+ (Figure 
3C). In contrast, analysis of E16.5–E17.5 embryonic skin, where 
there is active ongoing lymphangiogenesis, demonstrated that 
approximately 30% of LECs are Ki67+ (Figure 3D).
Using the whole-mount staining approach, we also character-
ized lacteals in different intestinal compartments. In the mouse 
small intestine, villus length decreased from the proximal duode-
num to the distal ileum (Figure 3E). Villi in the duodenum and 
jejunum frequently had on average two lacteals per villus, while 
most villi in the distal part of the intestine contained one lacteal 
(Figure 3, E and F). Such organization likely reflects the fact that 
most nutrient absorption occurs in the duodenum and jejunum. 
We next measured lacteal length as a percentage of the blood cap-
illary cage length and the number of filopodia/lacteal. Interest-
ingly, relative lacteal length was constant in the different intestinal 
segments (60%–70% of villus length), and the number of lacteal 
blasts (21). The SMC network extends throughout the entire vil-
lus length and is focally in close proximity to lacteals (Figure 1, 
E and F), whereas the terminal ends of SMC fibers are closely 
associated with villus blood capillaries (Figure 1G). Further anal-
ysis revealed that immune cells in the villus were closely asso-
ciated with the SMC fibers, including CD3+FOXP3+ regulatory 
T cells (Supplemental Figure 1D). F4/80+ macrophages were 
observed throughout the intestinal stroma; however, CD11chi 
DCs, sometimes sampling the intestinal lumen, were found at 
discrete locations along SMC fibers (Figure 2A), suggesting a 
scaffolding role for this network. Cells in the intestinal stroma 
are attached to and interact with the extracellular matrix (ECM). 
Interestingly, the highest levels of the ECM protein fibronectin 
were detected in intestinal villi, especially on SMC fibers (Figure 
2B). Integrins transduce signals from the ECM to promote cellu-
Figure 2. Immune cells and specialized ECM organization in adult 
small intestinal villi. Confocal microscope images of adult mouse small 
intestinal villi after whole-mount immunostaining. (A) DCs (CD11c, red) 
are closely associated with SMC fibers (αSMA, cyan). Inset: ×5 3D Surpass 
projection of DCs (CD11c, red) interacting with SMC fibers (arrowheads). 
DCs associated with SMC fibers can be observed sampling the intestinal 
lumen (arrow). Macrophages are shown in green (F4/80). (B) Fibronectin 
(green) is highly expressed on villus SMCs (αSMA, red). (C) Expression of 
periostin (red) and tenascin C (green) is restricted to the crypts (*) and villi, 
respectively. Scale bars: 50 μm, A–C.
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Figure 3. Lacteal regeneration in the adult small intestine. (A) Adult lacteals, but not dermal lymphatic capillaries (LYVE1, red), display filopodia. Filopo-
dia/lymphatic capillary (mean ± SD) in adult intestine and ear skin; n = 3–4. S.I., small intestine. (B) A small proportion of lacteal LECs are Ki67+ (PROX-
1+Ki67+DAPI+, white nuclei, arrowhead), while submucosal LECs (PROX1+DAPI+, pink nuclei, arrow) are quiescent. Percentage (mean ± SD) of Ki67+ LECs in 
the submucosal and lacteal lymphatic vessels of the small intestine; n = 8. (C) Adult ear skin LECs are quiescent (PROX1+DAPI+, pink nuclei). Percentage 
(mean ± SD) of Ki67+ LECs in adult ear skin; n = 4. (D) Embryonic skin LECs are actively proliferating (PROX1+Ki67+, yellow nuclei, arrowheads). Quiescent 
LECs are Ki67– (PROX1+DAPI+, pink nuclei, arrows). Percentage (mean ± SD) of Ki67+ LECs in E16.5–E17.5 embryonic skin; n = 3. (E) Relative lacteal length 
is constant along the entire small intestine. Whole-mount immunostaining of lacteals (LYVE1, red) and intestinal blood capillaries (PECAM1, green) 
from different intestinal segments of adult C57BL/6 mice. (F) The number of lacteals per villus (mean ± SD; n = 4) decreases from the duodenum to the 
ileum. (G) Quantification of relative lacteal length in the indicated parts of small intestine. Lacteal length/blood capillary cage length (mean ± SD); n = 4. 
(H) Quantification of lacteal filopodia in different parts of intestine. Filopodia/lacteal (mean ± SD); n = 4. Scale bars: 20 μm, A–D; 100 μm, E. *P < 0.05, 
2-tailed unpaired Student’s t test with Welch’s correction. duo, duodenum; jej, jejunum.
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cells of sprouting lacteals (Figure 4C), while lower but detectable 
levels of DLL4 were also present in stalk cells and throughout the 
entire lacteal length (Figure 4C and Supplemental Figure 2) and 
submucosal lymphatics (data not shown). Although DLL4 is a 
membrane-bound protein, mostly punctate perinuclear staining 
was observed, similar to previous observations (42, 48).
To further monitor Notch activity in intestinal lacteals, 
we analyzed CBF1:H2B-Venus mice, where CBF1 binding sites 
drive expression of histone H2B–Venus (49). In agreement 
with DLL4 expression patterns and consistent with the previ-
ously described Notch activity in these vessels, arterioles were 
highly Venus+, while venule BECs, stained for mucosal vascular 
addressin cell adhesion molecule 1 (MAdCAM-1), expressed 
lower levels or no transgene (Figure 4D and refs. 50, 51). Impor-
tantly, lacteals were intensely positive for Venus, suggesting a 
high level of Notch signaling (Figure 4E), although potential 
differences in Notch signaling between tip and stalk cells are 
likely blunted because of the long reporter protein half-life (52). 
These results thus demonstrated that lacteals in the adult small 
intestine have continuous Notch signaling, which may be at 
least in part mediated by DLL4.
filopodia per villus remained similar along the length of the intes-
tine (Figure 3, E, G, and H). Taken together, these observations 
suggested that adult lacteals, similar to intestinal epithelial cells, 
are in a constant state of regeneration, albeit much less prolifera-
tive than embryonic lymphatic vessels.
DLL4 maintains lacteal length and filopodia. Notch signaling 
regulates many aspects of BEC biology, including arteriovenous 
differentiation and angiogenesis (36, 37). The role of Notch dur-
ing sprouting lymphangiogenesis remains controversial: Notch 
signaling blockade was shown to both inhibit and promote lym-
phatic growth, suggesting a highly context-dependent role of 
this pathway (38–41). In BECs, the Notch ligand DLL4 is highly 
expressed in tip cells, where it regulates sprouting through the 
induction of Notch signaling in stalk cells (42–46); however, the 
expression pattern of DLL4 in the small intestine vasculature has 
not to our knowledge been studied. As expected, the highest lev-
els of DLL4 were observed in arterioles (Figure 4A) and interme-
diate “salt-and-pepper” levels were found in blood capillaries of 
intestinal villi (Figure 4B), while venules, identified by staining for 
the venous marker endomucin (47), expressed low levels of DLL4 
(Figure 4A). Of interest, high levels of DLL4 were observed in tip 
Figure 4. DLL4 expression and Notch signaling are high in 
adult lacteals. (A) DLL4 (white) displays perinuclear (arrows) 
and surface localization on villus arterioles. Endomucin 
(green) marks villus venules. Endothelial cells were identified 
by staining for zonula occludens 1 (ZO1, red). (B) DLL4 (white) 
is highly expressed on tip cells of villus blood capillaries 
(PECAM1, green). (C) DLL4 (white) is highly expressed on tip 
cells of villus lacteals (LYVE1, red); DAPI, blue. Dotted staining 
outside of lacteals is likely due to shedding from intestinal 
epithelial cells, where DLL4 was previously reported to be 
highly expressed (82). Relative DLL4 intensity (mean ± SD) in 
lacteal tip cells compared with neighboring stalk cells; n = 3. 
(D) Villus arterioles (VEGFR2, blue, arrowheads) have higher 
levels of Notch reporter (Venus, green) compared with venules 
(MAdCAM-1, red, arrows) in CBF1:H2B-Venus mice. Percentage 
(mean) Venus intensity of MAdCAM-1–negative arterioles 
versus MAdCAM-1–positive venules; n = 2. (E) Whole-mount 
immunostaining of lacteals (LYVE1, blue) and Venus (green) 
from adult CBF1:H2B-Venus mice. All LEC nuclei (PROX1, red) 
were also Venus+. Scale bars: 50 μm, A and D; 10 μm, B and C; 
20 μm, E. **P < 0.01, 2-tailed unpaired Student’s t test.
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To investigate the role of DLL4 in lacteals, we generated Dll4fl/fl 
Prox1-CreERT2 mice (hereafter referred to as Dll4ΔLEC mice), in 
which Dll4 deletion is induced in lymphatic vessels upon injec-
tion of tamoxifen. Adult Dll4ΔLEC and control mice were injected 
with tamoxifen, and the intestine was examined 3 and 10 weeks 
later. Efficient Dll4 deletion was confirmed by both DLL4 immu-
nostaining (Figure 5A) and quantitative reverse transcription PCR 
(RT-qPCR) for Dll4 on sorted LECs from control and Dll4ΔLEC 
intestine (Figure 5B). Quantification demonstrated a significant 
decrease in the number of filopodia in lacteals of Dll4ΔLEC compared 
with control mice (Figure 5C). In addition, 3 weeks after inactiva-
tion, Dll4ΔLEC mice had a tendency toward shorter lacteals, and after 
10 weeks of deletion Dll4ΔLEC lacteals were significantly shorter than 
those of control mice (Figure 5D). In contrast, no difference in the 
skin lymphatic vascular organization or density was observed (Sup-
plemental Figure 3). Control and Dll4ΔLEC mice had a similar num-
ber of Ki67+ intestinal LECs (Supplemental Figure 4A), suggesting 
that a decrease in lacteal LEC proliferation did not account for 
reduced lacteal length in Dll4ΔLEC mice. In addition, lacteals of con-
trol and Dll4ΔLEC mice had a similar cell density, but fewer total LECs 
(Supplemental Figure 4, B and C), suggesting that Dll4 inactivation 
impairs LEC survival and does not simply reduce cell size.
To compare the roles of DLL4 in blood and lymphatic intes-
tinal capillaries, we analyzed the intestine of mice with inducible 
inactivation of Dll4 in blood vessels using Dll4fl/fl Pdfgb-CreERT2 
mice. As observed previously in other vascular beds (44, 46, 53, 
54), loss of Dll4 resulted in a dramatic increase in filopodia, vessel 
branching, and the formation of sheet-like endothelial structures 
(Supplemental Figure 4D). With these results, we conclude that 
continuous DLL4 signaling is required for maintenance of lacte-
als, and the outcomes of DLL4 inactivation differ substantially in 
blood versus lymphatic capillaries.
DLL4 promotes lacteal LEC tip cell phenotype, survival, and effi-
cient migration. In BECs DLL4 expression confers competence 
to preferentially migrate to the tip cell position, as determined by 
competition assays in mosaic Dll4+/+/Dll4–/– embryoid bodies (42). 
Furthermore, LEC DLL4 overexpression promoted migration to 
the tip cell position in LEC spheroids in vitro (40). To study the in 
vivo function of DLL4 in lymphatic endothelial tip cell positioning, 
proliferation, and survival, we generated Dll4fl/fl Prox1-CreERT2 
Rosa26-EYFP mice, in which Cre-mediated recombination induces 
both deletion of Dll4 and YFP expression in LECs, while in con-
trol Prox1-CreERT2 Rosa26-EYFP mice, only YFP is expressed. 
We injected adults of both strains with a reduced concentration 
Figure 5. DLL4 is required for lacteal length main-
tenance. (A) Loss of DLL4 protein in Dll4ΔLEC lacteals. 
Whole-mount immunofluorescence staining for DLL4 
(red) and VEGFR3 (green) in WT and Dll4ΔLEC lacteals. 
(B) Efficient loss of Dll4 mRNA in Dll4ΔLEC LECs. Dll4 
expression (mean ± SD) in sorted intestinal LECs from 
WT and Dll4ΔLEC mice analyzed by RT-qPCR; n = 3. (C) 
Dll4 inactivation reduces lacteal filopodia (LYVE1, red). 
LYVE1 is intentionally overexposed to highlight lacteal 
filopodia (white dots). Filopodia/lacteal (mean ± SD) 
of control and Dll4ΔLEC mice 10 weeks after tamoxifen 
injection; n = 4–5. (D) Lacteals are shorter in Dll4ΔLEC 
mice. Representative images of villus blood capillaries 
(PECAM1, green) and lacteals (LYVE1, red) from control 
and Dll4ΔLEC mice after 10 weeks of Dll4 deletion. 
Lacteal length (mean ± SD) binned for given lengths 
3 weeks (top) and 10 weeks (bottom) after tamoxifen 
injection; n = 3. Scale bars: 10 μm, A; 20 μm, C;  
100 μm, D. *P < 0.05, ***P < 0.001, 2-tailed unpaired 
Student’s t test.
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of tamoxifen to induce mosaic Cre activation and then examined 
lacteals by whole-mount immunostaining after 3 weeks. Control 
lacteals had, on average, 40% YFP+ LECs; however, only 20% of 
LECs expressed YFP in Dll4ΔLEC animals (Figure 6, A and B). Further 
analysis of YFP+ LEC position in lacteals revealed that YFP+ cells in 
control animals were nearly twice as likely to be present in the tip 
cell position than YFP+ cells in Dll4ΔLEC mice, even after taking into 
account the reduced number of Dll4-deficient LECs (Figure 6, A and 
C). Quantification of the position of YFP+ LECs along the length of 
the lacteal also showed that YFP+ LECs in Dll4ΔLEC mice were found 
significantly lower on the lacteal than in control animals (Figure 6, 
A and D). Taken together, these results demonstrate a complex role 
for DLL4 in lacteals, where expression of DLL4 promotes both LEC 
survival and migration to the tip cell position.
We investigated whether lacteal DLL4 promotes LEC sur-
vival by costaining for PROX1 and caspase-3 on intestine sec-
tions from WT and Dll4ΔLEC mice. Epithelial cells at villus tips 
undergo apoptosis and slough off into the gut lumen. We found 
that although caspase-3+ differentiated epithelial cells could be 
readily detected in many villi, the number of caspase-3+ LECs 
in both the WT and Dll4ΔLEC mice was extremely low, making in 
vivo evaluation difficult (0.13% and 0.16%, respectively; Sup-
plemental Figure 4E and data not shown). To further investigate 
the direct role of DLL4 in cell survival, we analyzed LEC apop-
tosis after DLL4 knockdown in vitro (Supplemental Figure 4F), 
which also decreased expression of the Notch target genes HES1, 
HEY1, and NRARP (Supplemental Figure 4G). While less than 
0.5% of LECs transfected with control siRNA were caspase-3+, 
the number of caspase-3+ LECs was significantly increased after 
DLL4 inactivation (Figure 6E). Taken together with the in vivo 
data, demonstrating attrition of Dll4-deficient cells (Figure 6, 
A and B, and Supplemental Figure 4C), these results suggest 
that decreased cell survival of Dll4-deficient LECs is one of the 
mechanisms for decreased lacteal length.
Figure 6. DLL4 is required for LEC lacteal tip cell position and survival. (A) DLL4 expression is important for tip cell competence. Control (Prox1-CreERT2 
Rosa26-EYFP) and Dll4ΔLEC (Dll4fl/fl Prox1-CreERT2 Rosa26-EYFP) mice were injected with a reduced amount of tamoxifen to induce mosaic Cre activation. 
Representative images from WT and Dll4ΔLEC mosaic lacteals (YFP, green; PROX1, red; LYVE1, blue.) (B) Decreased number of Dll4-deficient LECs. Percent-
age (mean ± SD) of YFP+ LECs in mosaic Cre recombination control and Dll4ΔLEC Rosa26-YFP mice; n = 4. (C) Quantification of recombined YFP+ control or 
Dll4ΔLEC cells in tip position. Percentage (mean ± SD) of YFP+ lacteal tip cells in mosaic Cre recombination control and Dll4ΔLEC Rosa26-YFP mice; n = 4. (D) 
Quantification of recombined YFP+ control or Dll4ΔLEC cells position on vertical axis of the lacteal. Position of YFP+ lacteal cells in mosaic Cre recombination 
control and Dll4ΔLEC Rosa26-YFP mice as a percentage (mean ± SD) of lacteal length (lacteal base = 0, lacteal tip cell = 100); n = 4. (E) DLL4 depletion in 
vitro promotes apoptosis. Quantification of caspase-3+ LECs (caspase-3, red; β-catenin, green; DAPI, blue) 48 hours after transfection with two different 
siRNAs targeting DLL4. Mean percentage of caspase-3+ LECs. The graph represents pooled data of 2 independent experiments. Scale bars: 25 μm, A;  
20 μm, E. *P < 0.05, 2-tailed unpaired Student’s t test.
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induce DLL4 expression in cultured LECs (Supplemental Figure 
5A and ref. 40). Both receptors are highly expressed in lacteals 
(Supplemental Figure 1, A and B, and Supplemental Figure 5B). 
To determine whether ligand-dependent activation of VEGFR2 
or VEGFR3 contributes to DLL4 expression in lacteals, we treated 
adult mice with the VEGFR2- or VEGFR3-blocking antibodies 
DC101 (57) and mF4-31C1 (58), respectively.
Treatment with either blocking antibody for 7 days signifi-
cantly decreased lacteal DLL4 protein in vivo (Figure 8A), while 
treatment with VEGFR3 blocking antibodies also increased 
membrane staining for lacteal VEGFR3 (Supplemental Figure 
5B). To further study the role of VEGFR2 and VEGFR3 in DLL4 
regulation, we knocked down both receptors, individually and 
simultaneously, in primary LECs (Supplemental Figure 5C) and 
measured DLL4 levels following VEGFC treatment (Figure 8B). 
As expected, DLL4 was upregulated following VEGFC treat-
ment in LECs transfected with control siRNA. However, inacti-
vation of either VEGFR2 or VEGFR3 prevented DLL4 induction 
in response to VEGFC (Figure 8B). In addition, treating LECs 
with the VEGFR3-specific ligand VEGFC C156S also induced 
We next analyzed whether the decreased number of Dll4ΔLEC 
lacteal tip cells could be due to a defect in LEC migration. Time-
lapse microscopy was performed for 20 hours after “wounding” 
a monolayer of LECs transfected with control or DLL4-specific 
siRNAs and additionally treated with either BSA or VEGFC 
(Figure 7A and Supplemental Videos 1–4). Treatment with 
VEGFC increased the average total distance traveled by each 
cell; however, the average total distance remained unchanged 
between LECs transfected with control or DLL4-specific siRNA 
(Figure 7, A and B). In contrast, the actual distance traveled by 
siDLL4-transfected cells was decreased (Figure 7, A and C) and 
resulted in significant decreases in directionality (Figure 7D) in 
both BSA- and VEGFC-treated cells. These results suggest that, 
along with a decrease in LEC survival, inefficient LEC migration 
likely accounts for the decreased number of Dll4-deficient lac-
teal tip cells observed in vivo.
VEGFR3 signaling promotes DLL4 expression in lacteals. 
VEGFR2 and VEGFR3 are essential for embryonic angiogenesis 
and lymphangiogenesis, respectively (31, 55). VEGFA/VEGFR2 
signaling induces DLL4 in BECs (46, 56), and VEGFA and VEGFC 
Figure 7. DLL4 is necessary for efficient LEC migration. (A) Individual LEC migration was 
tracked for 20 hours after a wound was made in a LEC monolayer transfected with either 
control or DLL4-specific siRNA and treated with BSA or VEGFC. Tracks in red or black rep-
resent LECs that traveled less than or more than the average actual distance (avg. dist.), 
respectively. Data shown are representative of 3 independent experiments. (B) Total LEC 
track distance (mean ± SD) in arbitrary units (a.u.); n = 3. (C) Actual LEC distance (mean ± 
SD) traveled in arbitrary units; n = 3. (D) Directionality (actual/total distance; mean ± SD); 
n = 3. *P < 0.05, **P < 0.01, 2-tailed unpaired Student’s t test.
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gavaged Dll4ΔLEC and control animals with olive oil and measured 
accumulation of plasma triglycerides (TGs) and free fatty acids 
(FFAs) at different time points. Dll4ΔLEC mice had a significantly 
blunted increase in plasma TG and FFA levels compared with con-
trol animals (Figure 9A).
To gain a better mechanistic understanding of lacteal regres-
sion and impaired function, we analyzed the expression of previ-
ously identified targets and downstream effectors of DLL4/Notch 
signaling in LECs. However, despite efficient inactivation of Dll4 
(Figure 5, A and B), we did not observe significant changes in the 
levels of ephrin B2 (Efnb2), Vegfr3, or Lyve1 (Figure 5D, Supple-
mental Figure 6, A and B; ref. 38), suggesting different underlying 
mechanisms. Mature lymphatic capillaries display a unique junc-
tional organization, in which borders of oak leaf–shaped endo-
thelial cells are discontinuously sealed by button-like junctions, 
containing both adherens and tight junction proteins, such as VE-
DLL4 expression, albeit to a lesser extent than with WT VEGFC 
(Figure 8C). Thus, we conclude that ligand-dependent VEGFR3 
and VEGFR2 signaling is the main inducer of DLL4 expression 
in lacteals. Consistent with these observations, VEGFR2- and 
VEGFR3-blocking antibodies reduced the number of lacteal 
filopodia (Figure 8D). Further analyses of lacteal length demon-
strated that blocking VEGFR3 signaling resulted in a slight but 
significant reduction in lacteal length, while a tendency to have 
shorter lacteals was observed in DC101-treated animals (Fig-
ure 8E). Thus, we conclude that active VEGFR3 and, to a lesser 
extent, VEGFR2 signaling are necessary for lacteal length and 
filopodia maintenance in adult small intestinal villi.
Lymphatic DLL4 is necessary for lacteal function. One of the pri-
mary roles of lacteals is the transport of dietary long-chain fatty 
acids, secreted from enterocytes in the form of lipoprotein parti-
cles called chylomicrons (59). To study chylomicron transport, we 
Figure 8. DLL4 expression is dependent on active VEGFR3 and VEGFR2 signaling. (A) Whole-mount immunostaining of DLL4 (white, arrow) on lacteals 
(LYVE1, red) of mice treated with control IgG, αVEGFR2, or αVEGFR3 blocking antibodies. Perinuclear DLL4 intensity/lacteal volume (mean ± SD); n = 3. (B) 
Serum-starved LECs transfected with control, VEGFR2, VEGFR3, and VEGFR2/VEGFR3 (R2+R3) siRNA were treated for 24 hours with either BSA or VEGFC 
and analyzed by Western blotting. Data are representative of 2 independent experiments. (C) Serum-starved LECs were treated with BSA, VEGFC, and 
VEGFC C156S for 24 hours and analyzed by Western blotting. Data are representative of 2 independent experiments. (D) Quantification of lacteal filopodia 
after αVEGFR2 or αVEGFR3 treatment. LEC filopodia/villus (mean ± SD); n = 3. (E) Representative whole-mount images of intestinal villus blood capillar-
ies (PECAM1, green) and lacteals (LYVE1, red) after αVEGFR2 or αVEGFR3 treatment. Lacteal length (mean ± SD) binned for given lengths after 2 weeks of 
antibody administration; n = 3. Scale bars: 10 μm, A; 50 μm, E. *P < 0.05, **P < 0.01, ***P < 0.001, 2-tailed unpaired Student’s t test (E) or 1-way ANOVA 
with Bonferroni correction (A and D).
The Journal of Clinical Investigation   R e s e a R c h  a R t i c l e
4 5 8 1jci.org   Volume 125   Number 12   December 2015
capacity (60, 62). At the same time, lymphatic collecting vessels 
have continuous cell-cell junctions, important for avoiding lymph 
leakage during transport from capillaries to lymph nodes (60). To 
better understand the molecular mechanisms of impaired chylo-
micron transport in Dll4ΔLEC mice, we analyzed the organization 
of cell-cell junctions in intestinal lymphatic vessels by staining for 
cadherin and claudin-5, respectively (60). Such junctional orga-
nization is functionally important, as flap-like openings between 
adjacent “buttons” allow unimpeded access of interstitial fluid 
and immune cells into the lymphatic capillary lumen (60, 61). Of 
interest, actively growing lymphatic vessels display continuous 
cell-cell junctions, which likely reduce their uptake and transport 
Figure 9. Lymphatic DLL4 is necessary for fat uptake and discontinuous lacteal adherens junctions. (A) Quantification of plasma TGs and FFAs in olive 
oil–gavaged WT and Dll4ΔLEC mice. Plasma TG and FFA (mean ± SD) at indicated time points in WT and Dll4ΔLEC mice; n = 3. (B) Representative whole-mount 
images of submucosal lymphatic capillaries (LYVE1, green; VE-cadherin, red) from control and Dll4ΔLEC mice. Arrows indicate button-like junctions that are 
present in both WT and Dll4ΔLEC submucosal lymphatic capillaries. (C) Top: Representative whole-mount images of lacteals (LYVE1, green; VE-cadherin, 
red) from control and Dll4ΔLEC mice. White arrowheads, continuous junctions; white arrows, discontinuous junctions. Bottom: Representative high-magni-
fication images of single lacteal LECs (VE-cadherin, black) from control and Dll4ΔLEC mice. (D) Quantification of lacteals with continuous, discontinuous, or 
mixed staining for VE-cadherin from control and Dll4ΔLEC mice. Percentage (mean ± SD) of lacteals in each group from control and Dll4ΔLEC mice; n = 5. Scale 
bars: 10 μm, B and C (top); 5 μm, C (bottom). *P < 0.05, **P < 0.01, ***P < 0.001, 2-tailed unpaired Student’s t test.
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VE-cadherin and LYVE1. Submucosal lym-
phatic vessels in both control and Dll4ΔLEC 
mice displayed the expected oak leaf–shaped 
pattern and button-like staining of LYVE1, 
with discontinuous localization of VE-cad-
herin (Figure 9B and ref. 60). Interestingly, 
lacteals in WT mice showed a mix of both 
continuous and discontinuous junctions 
(Figure 9C), demonstrating that they have 
features of both sprouting and quiescent lym-
phatic capillaries. Importantly, loss of DLL4 
resulted in formation of continuous VE-cad-
herin junctions in all cells, which, together 
with reduced lacteal surface, likely explains 
impaired chylomicron uptake in these ani-
mals (Figure 9, C and D).
Discussion
Intestinal lymphatic vasculature plays a 
key role in the absorption and transport of 
dietary fat and in the regulation of immune 
surveillance in the gut. It is also likely that 
intestinal lymphatic vessel dysfunction 
contributes to several common diseases of 
industrialized societies, such as metabolic 
syndrome, inflammatory bowel diseases, 
and colon cancer. Furthermore, intesti-
nal lymphatic vasculature is an attractive 
emerging target for mucosal vaccination and 
drug delivery, by virtue of direct access to 
the lymph node and bypass of liver metab-
olism. Despite the important physiological 
and pathophysiological roles of intestinal 
lymphatics, surprisingly little is known about 
the mechanisms that regulate their mainte-
nance and function in the adult state. Here 
we report that lymphatic vessels in adult 
small intestinal villi are constantly regener-
ating and that continuous Notch signaling 
is necessary to maintain the optimal length, 
junctional organization, and function of lac-
teals (Figure 10).
Detailed characterization of adult lac-
teals revealed that they undergo continuous 
and slow remodeling (Figure 3). Unlike most 
other capillary beds, the vessels of small 
intestinal villi are continuously exposed to 
high concentrations of lipoprotein particles 
and other biologically active dietary and 
microbial products, such as retinoic acid (2) 
or Toll-like receptor ligands (63); gradients 
of osmolarity (64); and high mechanical 
strain due to peristalsis and villus contrac-
tions (23). Furthermore, the adult intestine is 
in a constant state of renewal, as the mouse 
epithelium is wholly replaced every 5 days 
(65). Thus, we believe that lacteal remodel-
Figure 10. DLL4 promotes continuous lacteal regeneration in the adult small intestine.  
(A) During normal homeostasis the intestinal villi are subject to many stressors, including 
dietary fat, the gut microbiota, and villus movements, which lacteals encounter as chylomi-
crons, TLR ligands, and mechanical stress, respectively. In normal mice, VEGFC/D signaling, 
through VEGFR2 and VEGFR3, promotes lacteal DLL4 expression and Notch signaling, thus 
maintaining LEC survival, sprouting, and migration to replace damaged cells. Furthermore, 
LECs in lacteals have both continuous and discontinuous adherens junctions, balancing the 
need for continuous regeneration with the need for efficient chylomicron uptake. (B) In the 
absence of DLL4, lacteals are unable to undergo remodeling and have impaired survival and 
migration and thus are not able to maintain the normal length in villi. Lymphatic Dll4 deletion 
also promotes a shift from mixed adherens junctions to mostly continuous junctions, contrib-
uting to inefficient chylomicron uptake and transport. MLN, mesenteric lymph node.
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between adherens junction plasticity and stabilization to allow 
efficient uptake of chylomicrons while also maintaining lacteal 
length through regeneration.
Our study also highlights intriguing similarities and differ-
ences in the usage of the Notch pathway by blood and lymphatic 
vessels. In both vessel types, DLL4 confers competence to pref-
erentially migrate to the tip cell position (Figure 6, A and C, and 
refs. 40, 42); however, vessel hypersprouting and increased 
proliferation in the absence of DLL4 occurs only in BECs but 
not lacteal LECs. The latter, in contrast, show impaired survival 
and migration. Theoretically, such dissimilar behavior may be 
due to tissue-specific differences in production and gradients 
of angiogenic versus lymphangiogenic growth factors. Indeed, 
in our experiments we observed a preference for Dll4-deficient 
cells to remain in the lower part of the lacteal (Figure 6D), 
which is likely a result of the cell migration defect (Figure 7). 
Such nonmigrating cells might also reside in areas with low 
lymphangiogenic growth factor concentrations, and thus, with 
time, they will be depleted due to impaired cell survival. Alter-
natively, it is possible that the intracellular signaling down-
stream of Notch receptors differs in blood and LECs, possibly 
in a context-dependent manner. Since the in vitro responses of 
BECs and LECs to DLL4 inhibition are rather comparable (40, 
42), it will be important in the future to establish the microen-
vironmental determinants of such distinct responses in vivo, 
for example by comparing the role of DLL4 in lymphangiogenic 
responses in different adult and embryonic tissues. Of interest, 
previous studies (70–72) demonstrated differential require-
ments for lymphatic vascular growth during the early postnatal 
period versus adulthood, and we found that inactivation of Dll4 
at P1 did not inhibit lacteal expansion by P7 (data not shown). 
Taken together, these results further support the idea that 
distinct mechanisms are involved in lymphangiogenic vessel 
expansion versus regeneration in adult tissues.
Our results also raise important clinically relevant questions. 
Previous studies demonstrated that anti-angiogenic treatments 
(soluble VEGFR1; anti-VEGF and anti-VEGFR2 blocking anti-
bodies) affect normal blood vessels in the organs with fenes-
trated endothelial cells, including the intestine, in addition to 
pathological vasculature (33, 34). As therapeutic agents targeting 
DLL4 signaling in tumor vasculature are in clinical trials (73), 
our study highlights the need to consider potential side effects of 
such treatment on intestinal vessel function. Last, we have shown 
one molecular mechanism of lacteal maintenance and how this 
directly affects lipid uptake into the bloodstream through lym-
phatic vessels. Further studies of such mechanisms may be of use 
for delivery of oral drugs, and the ability to shunt the route of orally 
administered drugs to either the lymphatic or blood system would 
be a major advance in drug delivery technology (74).
Methods
Animal models. Dll4fl/fl, Pdgfb-CreERT2, Prox1-CreERT2, Rosa26-
EYFP, and CBF1:H2B-Venus mice were previously described (27, 49, 
75–77). Cre-mediated deletion was induced in 8- to 12-week-old mice 
either by i.p. (50 mg/kg mouse) or subcutaneous injection (100 mg/
kg mouse) of tamoxifen in sunflower oil (Sigma-Aldrich). Mosaic 
deletion in Dll4fl/fl Prox1-CreERT2 Rosa26-EYFP and Prox1-CreERT2 
ing reflects a need for continuous lacteal regeneration due to the 
unique small intestine microenvironment, which itself is con-
stantly renewing.
Mechanistically, we show that DLL4/Notch signaling, act-
ing downstream of VEGFR3 and VEGFR2, mediates part of such 
a maintenance and regeneration program in lacteals. Although 
mechanical signals were shown to induce LEC proliferation dur-
ing embryonic lymphangiogenesis through β1 integrins (26), in the 
adult intestinal villi Itgb1 is expressed at much lower levels in LECs 
than villus SMCs (Supplemental Figure 1E), perhaps accounting for 
lower levels of LEC proliferation in adult lacteals compared with 
embryonic lymphatic vessels. The role of Notch signaling in mam-
malian lymphatic vasculature has been investigated previously in 
several contexts. Developmental studies suggested that this path-
way limits LEC differentiation and regulates skin lymphatic vessel 
sprouting (39, 41). Treatments using DLL4- and NOTCH1-block-
ing antibodies impaired both postnatal lymphangiogenesis and 
recruitment of SMCs to collecting lymphatic vessels (38), while 
studies of adult ear lymphangiogenesis using DLL4-Fc fusion 
protein suggested an opposite effect, due to increased responsive-
ness of LECs to VEGFA (40). Thus, the role of Notch signaling in 
lymphatic vasculature seems to be highly context dependent, as in 
the blood vasculature. Indeed, it was recently demonstrated that 
Notch activation, which in the pup retina leads to vessel quies-
cence and normalization (44, 66), instead increased bone marrow 
blood vessel density in young mice (67). Therefore, further inves-
tigation is needed to elucidate specific mechanisms determining 
endothelial response to Notch signaling.
Here, using genetic ablation of Dll4 in LECs, we demon-
strate that DLL4 in adult lacteals promotes efficient migra-
tion and acquisition of the tip cell position, in agreement with 
in vitro mosaic LEC sprouting competition assays by Zheng et 
al. (40), and LEC survival, which is broadly in agreement with 
the role proposed by Niessen et al. (38). However, we did not 
observe significant changes in the expression or localization of 
Efnb2, Vegfr3, or Lyve1 in lacteals (Figure 5D and Supplemental 
Figure 6, A and B), nor defects in collecting lymphatic vessels 
of Dll4ΔLEC mice (J. Bernier-Latmani, unpublished observation). 
Rather, we show that the expression of DLL4 itself is induced 
through the activation of VEGFR3/VEGFR2 signaling, which 
places VEGFR3/VEGFR2 upstream of the DLL4/Notch signal-
ing cascade (Figure 10). The exact molecular details of DLL4/
Notch signaling in LECs remains to be investigated, and they 
may indeed be highly organ- or context-specific. Here, we show 
that one of the main consequences of genetic Dll4 inactivation 
is stabilization of lymphatic endothelial cell-cell junctions. Pre-
vious studies of BECs demonstrated that dynamic remodeling 
of VE-cadherin is a prerequisite for efficient tip cell positioning 
(68). Furthermore, stabilization of endothelial cell-cell con-
tacts in mice bearing VE-cadherin fused with α-catenin strongly 
impairs formation of lymphatic vessels during embryogenesis 
(69). Thus, abnormal stabilization of adherens junctions may 
both underlie the inability of Dll4-deficient LECs to efficiently 
migrate to occupy the tip cell position and, at the same time, 
lead to the impairment of chylomicron uptake and reduction of 
lacteal transport capacity. Therefore, these observations sug-
gest that an equilibrium must be maintained in adult lacteals 
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Cell culture and treatment. Primary LECs were isolated as 
described previously (13) and cultured in complete EBM-2 (Lonza). 
For VEGFC treatment, LECs were plated (on coverslips for cell stain-
ing) and serum starved for 16 hours prior to treatment with BSA, 
VEGFC (100 ng/ml), or VEGFC C156S (300 ng/ml, R&D Systems) 
for either 24 hours (Western blotting) or 48 hours (cell staining). For 
apoptosis analysis, cells were plated on coverslips and transfected 
with control or DLL4-specific siRNA and grown for 48 hours. Cov-
erslips were fixed in 4% PFA prior to immunostaining. For migration 
analysis, cells were plated on glass-bottomed plates and transfected 
with control or DLL4-specific siRNA and grown for 48 hours, after 
which the monolayer was scratched using a pipette tip and medium 
containing BSA or VEGFC was added. Cells along the scratched area 
were recorded by time-lapse microscopy every 15 minutes for 20 
hours using an Axio Observer Z1 microscope with stage-top incuba-
tor. Antibodies used for cell staining or Western blotting are listed in 
Supplemental Table 1, and siRNAs are listed in Supplemental Table 3.
Quantification. Lacteal length was measured using images of villus 
PECAM1 and LYVE1 immunostaining and the lymphatic vessels density 
plugin for ImageJ (80). Lacteal length was measured and normalized by 
the blood capillary cage length. Quantification of lacteal filopodia and VE-
cadherin–stained junctions was performed by examination with a Zeiss 
Axio Imager Z1 with ×63 objective by an observer blinded to the experi-
mental protocol. For both quantifications at least 50 lacteals were analyzed 
per sample. Dermal lymphatic capillary length and branchpoint quantifi-
cation was performed using AngioTool (https://ccrod.cancer.gov/conflu-
ence/display/ROB2/Home; ref. 81) after input of capillary network over-
lays drawn in Photoshop. Lacteal DLL4 expression was quantified using 
3D reconstruction by masking the DLL4 signal to lacteal LYVE1 staining 
and quantifying perinuclear DLL4 using the Spots module in Imaris. A 
similar protocol was also used to quantify YFP expression in CBF1:H2B- 
Venus mice. Quantification of LEC migration was performed manually 
using the Track Points application in the MetaMorph software package. 
Statistical analysis and graphing of migration data were performed using 
the Chemotaxis and Migration Tool plugin for ImageJ (Ibidi).
Statistics. Two-tailed unpaired Student’s t test or 1-way ANOVA 
was performed to determine statistical significance by calculating 
the probability of difference between two means, with a Bonferroni 
correction performed to account for multiple testing or Welch’s cor-
rection to account for differences in variance where noted. P values 
less than 0.05 were considered statistically significant. Data are 
shown as mean ± SD.
Study approval. Animal experiments were approved by the Animal 
Ethics Committee of Vaud, Switzerland, and the CNIC and Madrid 
Council Ethics Committee.
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Rosa26-EYFP mice was induced by i.p. injection of tamoxifen (7.5 mg/
kg mouse). DC101 and mF4-31C1 blocking antibodies, which block 
the interaction of ligands with VEGFR2 and VEGFR3, respectively, 
were described previously (57, 58). Anti-VEGFR2, anti-VEGFR3, and 
control rat anti-HRP IgG (BioXCell) were delivered by i.p. injections 
(40 mg/kg mouse) every 3 days. For fat gavage and blood sampling, 
mice were injected with tamoxifen as described above 3 weeks prior 
to treatment. Mice were gavaged with 200 μl olive oil (Sigma-Aldrich) 
after being fasted for 6 hours. Blood was sampled at 0, 1, 2, and 3 hours 
after gavage by tail vein collection in EDTA-coated tubes. TG and FFA 
analysis was performed on a Cobas C111 (Roche Diagnostics).
Mouse tissue collection, staining procedures, and image acquisition. 
Small intestine whole-mount staining was performed as in Stappen-
beck et al. (78) with modifications. Prior to sacrifice anesthetized mice 
were perfused with 4% paraformaldehyde (PFA) by cardiac punc-
ture. The small intestine was then quickly dissected in ice-cold PBS, 
cleaned, cut longitudinally, and pinned on silicon plates. Intestines 
were then fixed overnight at 4°C in 15% picric acid, 0.5% PFA, and 0.1 
M sodium phosphate. Samples were washed 3 times in ice-cold PBS 
for 5 minutes and subsequently washed 3 hours with 10% sucrose in 
PBS and overnight in 20% sucrose, 10% glycerol in PBS. Following 
the last wash step, samples were stored in 0.1% sodium azide in PBS. 
Epithelial cells were removed for whole mount immunostaining with 
anti-DLL4, -NG2, -endomucin, –tenascin C, and -periostin antibod-
ies, using 10 minutes of incubation in 1 mM EDTA on ice after PFA 
perfusion fixation and dissection. For ear whole-mount and intestinal 
sections, tissues were dissected and fixed in cold 4% PFA. Whole-
mount and paraffin section immunostaining was performed as pre-
viously described (79). Primary antibodies are listed in Supplemen-
tal Table 1. Alexa Fluor 488, 555, and 647 fluorochrome–conjugated 
secondary antibodies (Invitrogen) were used for signal detection. 
Nuclei were detected with DAPI. Confocal images were obtained 
using either a Zeiss LSM 510 META or Leica SP5 TANDEM micro-
scope, and standard fluorescence images were obtained using a Zeiss 
Axio Imager Z1 and analyzed using Imaris (Bitplane), ImageJ (http://
imagej.nih.gov/ij/), and Photoshop (Adobe) software.
Intestinal LEC sorting. LECs were isolated from adult intestine 
using cell sorting. Briefly, mice were sacrificed, and the intestine 
was dissected and flushed with ice-cold PBS. Peyer’s patches were 
removed and the intestine was cut into 1 cm pieces, which were put 
in a 10 mM EDTA solution with agitation at 37°C for 30 minutes to 
remove epithelial cells. The remaining tissue was then digested with 
Collagenase IV (3 mg/ml) in complete DMEM (Gibco; ThermoFisher 
Scientific) containing CaCl2 (2 mM) and 50 μg/ml DNase I (with con-
stant stirring at 37°C) for 20 minutes and washed with medium. The 
cell suspension was incubated with labeled antibodies listed in Sup-
plemental Table 1. FACS sorting was performed on a BD FACSAria 
IIu (BD Biosciences).
RNA isolation and RT-qPCR. Total RNA was isolated using the 
QIAGEN RNeasy Plus Micro Kit. Reverse transcription was per-
formed using Transcriptor First Strand cDNA Synthesis Kit (Roche 
Diagnostics). Alternatively, mRNA was amplified using Ovation Pico 
WTA System V2 (NuGEN). RT-qPCR analyses were performed using 
StepOnePlus (Applied Biosystems) using SYBR Fast PCR Master Mix 
(Kapa Biosystems). Analysis of gene expression was carried out using 
the comparative Ct (ΔΔCt) method as described by the manufacturer. 
Sequences of PCR primers are provided in Supplemental Table 2.
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